Navigation Links
NuVasive Announces Web Cast and Conference Call of Third Quarter 2007 Results
Date:9/27/2007

SAN DIEGO, Sept. 27 /PRNewswire-FirstCall/ -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today details relating to its third quarter 2007 earnings announcement, which will take place on Wednesday, October 24, 2007, after the close of the market.

NuVasive will hold a conference call on Wednesday, October 24, 2007 at 5:00 p.m. ET / 4:00 p.m. CT to discuss the results. The dial-in numbers are 1-877-407-4018 for domestic callers and 1-201-689-8471 for international. A live Web cast of the conference call will be available online from the investor relations page of the Company's corporate Web site at http://www.nuvasive.com.

After the live Web cast, the call will remain available on NuVasive's Web site, http://www.nuvasive.com, through November 24, 2007. In addition, a telephonic replay of the call will be available until November 14, 2007. The replay dial-in numbers are 1-877-660-6853 for domestic callers and 1-201-612-7415 for international callers. Please use account number 3055 and conference ID number 256798.

About NuVasive

NuVasive is a medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders. The Company's product portfolio is focused on applications in the over $3.6 billion U.S. spine fusion market. The Company's current principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery, or MAS(TM), as well as a growing offering of cervical and motion preservation products.

The MAS platform offers advantages for both patients and surgeons such as reduced surgery and hospitalization time and faster recovery. MAS combines three categories of current product offerings: NeuroVision(R) a proprietary softwar
'/>"/>

SOURCE NuVasive, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...assessing traditional risk factors, experts say ,...wo molecular signs -- or "biomarkers" -- of inflam...to assess a person,s risk of stroke, new research ... adding these markers does not change things much,...logist at the Methodist DeBakey Heart & Vascul...
(Date:1/8/2009)...ption business continues to drive overall performa...- Zix Corporation (ZixCorp(R)), (Nasdaq: ZIXI ),...n and e-prescribing, today offered a corporate upd... , "We ended the year on a high note in our Emai...ders for the year in the fourth quarter," said Spu...
(Date:1/8/2009)... A proposal by the State...ors Children,s Home has prompted the 125,000-membe...its annual Mid-Winter conference January 10-12, 20...s, nearly unanimous opposition to the proposal. ,... $50,000 in direct and in-kind support to the home...
(Date:1/8/2009)... Missile Strikes , , NEW YORK, Jan. 8 /PRNewsw... and the Jewish Federations of North America today...arian and social needs in southern Israel, part of...rity with Israelis during the current conflict wit...the Gaza Strip. , , The funds will enhance pro...
Breaking Medicine News(10 mins):Health News:Inflammation Markers May Help Predict Stroke Risk 2Health News:Inflammation Markers May Help Predict Stroke Risk 3Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 2Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 3Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 4Health News:UJC and Jewish Federations of North America Commit $10 Million for Needs in Southern Israel 2
...or people suffering diabetic retinopathy. The trea...leviating the effects of diabetic retinopathy,// w...etes. In the initial stages, retinopathy does not...apable of progressing gradually to cause the blood...
...t a single counseling intervention that includes a... contexts may have an impact on HIV// prevention b...blished in the April 15th edition of the Journal o...ble evidence exists that alcohol use contributes t...
...tective shield in early childhood. But new researc...ugh to adolescence and adulthood. Child// fed on b... on bottle feed. The earlier study had pressed t... that breast feed was necessary to reduce childhoo...
...at took place last week at the Virginia Tech Many ...re asking the congressmen to formulate some// meas...f program, to identify and treat the mentally ill,...aw that would permit the university to inform the ...
Other Medicine News:Health News:Brief Intervention on HIV and Alcohol Risk Encourages Safer Sex 2Health News:Brief Intervention on HIV and Alcohol Risk Encourages Safer Sex 3Health News:Measures Needed to Avert Another Bloodbath 2
(Date:1/6/2009)...re-FirstCall/ -- , - Early Renewal of the A...er 2011 , - Expansion of the Scope of the C...thalmology , - Revised Commercial Terms and... Third Party , ExonHit Therapeutics (Alte...its existing drug discovery collaboration with All...
(Date:1/5/2009)...FirstCall/ -- Micromet, Inc.,(Nasdaq: MITI ), a...ietary,antibodies for the treatment of cancer, in...utlook on key events anticipated for the year 2009... on its research and development,programs at the ...: Update on several preclinical BiTE antibodies at...
(Date:1/3/2009)...Ill., Jan. 2 Magnetic r...viding an increasing number of clinical benefits w...to an article in the January 2009 issue of the Jou...ns ( http://www.jaaos.org/ ). It is predicted tha...l developments will allow MRI to provide even more...
(Date:12/29/2008)...ewswire/ -- The winner of the 2008 Award for Excel...oday by Dr. Peter G. Goldschmidt, President and Fo... The winner of the annual award was the Univers... its best practice " IND Regulatory and Monitoring...human subjects protection, 2) improved data qualit...
Breaking Medicine Technology:ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 5MRI Emerges As Vital Resource in Treatment of Back Pain 2MRI Emerges As Vital Resource in Treatment of Back Pain 32008 Human Research Protection Award Recipients Announced 2New nanostructured thin film shows promise for efficient solar energy conversion 2511 1New nanostructured thin film shows promise for efficient solar energy conversion 2511 2New nanostructured thin film shows promise for efficient solar energy conversion 2511 3Irell 26 Manella Posts Strong Year for Corporate Transactions 9284 1Irell 26 Manella Posts Strong Year for Corporate Transactions 9284 2Irell 26 Manella Posts Strong Year for Corporate Transactions 9284 3Irell 26 Manella Posts Strong Year for Corporate Transactions 9284 4Irell 26 Manella Posts Strong Year for Corporate Transactions 9284 5Irell 26 Manella Posts Strong Year for Corporate Transactions 9284 6AMERIGROUP Community Care of Georgia Wins New Health Plan Accreditation from NCQA 9280 1AMERIGROUP Community Care of Georgia Wins New Health Plan Accreditation from NCQA 9280 2Round Table Family Charities Raises 24350 000 for Childrens Miracle Network 9276 1Round Table Family Charities Raises 24350 000 for Childrens Miracle Network 9276 2
...-- Shire plc,announced today the positive results ...acine extended release (GXR,previously referred t...onist. These data from two short-term phase,III pl...II,open-label studies, presented at the 2007 Ameri...demonstrated that GXR,significantly improved all c...
...onoclonal Antibody,Targeting Interleukin-9 (IL-9);...-9 Inhibition in Developing Potential Asthma,Thera...FirstCall/ --,MedImmune, Inc. today announced the ...within the company,s inflammatory,disease pipeline...ies with its monoclonal antibody (MAb) targeting I...
Other Medicine Technology:Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 2Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 3Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 4Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 5Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 6Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 7Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 8MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 2MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 3MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 4MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 5MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 6MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 7
Ready to use liquid single reagent for automated chemistry analyzers. Linearity to 1000 mmol/L
The Proteineer suite integrates powerful mass spectrometers with robotics and bioinformatics to deliver maximum productivity in high-throughput proteomics.
The ProteomeLab PA 800 resolves and quantifies proteins by their isoelectric point and molecular weight, generates high-resolution peptide maps and carbohydrate profiles and provides front-end separa
Storage temperature: 2 - 8C, linearity: 0 - 700 mg/dL, expected values: 30 - 780 mg/dL. Available with calibrator and number of tests 110.
Medicine Products: